Activation of TRPM3 by a potent synthetic ligand reveals a role in peptide release
- Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):E1363-72. doi: 10.1073/pnas.1419845112.
- 1. Laboratory of Obstetrics and Experimental Gynecology and Laboratory of Ion Channel Research and Transient Receptor Potential Research Platform Leuven, Catholic University of Leuven, B-3000 Leuven, Belgium;
- 2. Institute of Physiology and Pathophysiology, University of Erlangen-Nuremberg, D-91054 Erlangen, Germany; and.
- 3. Laboratory of Obstetrics and Experimental Gynecology and.
- 4. Center for Innovation and Stimulation of Drug Discovery Leuven and.
- 5. Center for Innovation and Stimulation of Drug Discovery Leuven and Center for Drug Design and Discovery, Bio-Incubator 2, B-3001 Heverlee, Belgium.
- 6. Laboratory of Ion Channel Research and Transient Receptor Potential Research Platform Leuven, Catholic University of Leuven, B-3000 Leuven, Belgium;
- 7. Laboratory of Obstetrics and Experimental Gynecology and [email protected].
Transient receptor potential (TRP) cation channel subfamily M member 3 (TRPM3), a member of the TRP Channel superfamily, was recently identified as a nociceptor channel in the somatosensory system, where it is involved in the detection of noxious heat; however, owing to the lack of potent and selective agonists, little is known about Other potential physiological consequences of the opening of TRPM3. Here we identify and characterize a synthetic TRPM3 activator, CIM0216, whose potency and apparent affinity greatly exceeds that of the canonical TRPM3 agonist, pregnenolone sulfate (PS). In particular, a single application of CIM0216 causes opening of both the central calcium-conducting pore and the alternative cation permeation pathway in a membrane-delimited manner. CIM0216 evoked robust calcium influx in TRPM3-expressing somatosensory neurons, and intradermal injection of the compound induced a TRPM3-dependent nocifensive behavior. Moreover, CIM0216 elicited the release of the peptides Calcitonin gene-related peptide (CGRP) from sensory nerve terminals and Insulin from isolated pancreatic islets in a TRPM3-dependent manner. These experiments identify CIM0216 as a powerful tool for use in investigating the physiological roles of TRPM3, and indicate that TRPM3 activation in sensory nerve endings can contribute to neurogenic inflammation.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: TRP ChannelResearch Areas: Neurological Disease